Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
29.11
-2.43 (-7.70%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sensei Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -21.09 | -30.16 | -34.1 | -48.59 | -36.79 | |
| Depreciation & Amortization | 0.14 | 1.32 | 1.35 | 1.35 | 0.69 | |
| Loss (Gain) From Sale of Assets | - | - | 0.3 | -0.02 | -0.03 | |
| Asset Writedown & Restructuring Costs | - | 0.95 | - | - | - | |
| Loss (Gain) From Sale of Investments | -0.7 | -0.99 | -1.06 | 0.22 | 0.62 | |
| Stock-Based Compensation | 1.27 | 3.14 | 4.45 | 5.81 | 5.66 | |
| Other Operating Activities | 1.51 | 1.55 | 1.36 | 1.19 | -0.51 | |
| Change in Accounts Payable | 0.23 | -0.45 | -2.33 | 2.02 | -1.43 | |
| Change in Other Net Operating Assets | -1.83 | -0.04 | -2 | -1.01 | 1.54 | |
| Operating Cash Flow | -20.45 | -24.67 | -32.02 | -39.03 | -30.26 | |
| Capital Expenditures | -0.02 | -0.15 | -0.18 | -0.32 | -2.03 | |
| Sale of Property, Plant & Equipment | 0.25 | - | 0.17 | 0.02 | 0.32 | |
| Investment in Securities | 19.54 | 22.59 | 38.43 | 50.26 | -141.41 | |
| Investing Cash Flow | 19.77 | 22.44 | 38.41 | 49.95 | -143.12 | |
| Long-Term Debt Repaid | -0.79 | -0.81 | -0.76 | -0.63 | -0.26 | |
| Net Debt Issued (Repaid) | -0.79 | -0.81 | -0.76 | -0.63 | -0.26 | |
| Issuance of Common Stock | 0.01 | 0.03 | 0.05 | 0.34 | 140.7 | |
| Repurchase of Common Stock | -0 | -0.01 | -10.46 | - | - | |
| Other Financing Activities | 0.14 | - | - | - | - | |
| Financing Cash Flow | -0.65 | -0.79 | -11.17 | -0.29 | 163.94 | |
| Net Cash Flow | -1.33 | -3.02 | -4.78 | 10.64 | -9.44 | |
| Free Cash Flow | -20.47 | -24.82 | -32.2 | -39.35 | -32.29 | |
| Free Cash Flow Per Share | -16.23 | -19.76 | -23.04 | -25.63 | -23.30 | |
| Levered Free Cash Flow | -12.61 | -14.71 | -21.38 | -22.49 | -17.56 | |
| Unlevered Free Cash Flow | -12.59 | -14.65 | -21.29 | -22.36 | -17.14 | |
| Change in Working Capital | -1.59 | -0.49 | -4.33 | 1.01 | 0.12 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.